NCT02638090 2025-12-22Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)H. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Active not recruiting120 enrolled 14 charts